Innovative Disease Prevention US BIOLOGIC specializes in developing groundbreaking orally delivered vaccines, offering a unique opportunity to provide clients with advanced, cost-effective solutions for disease prevention in both wildlife and domestic animals, as well as humans.

Recent Product Launches The launch of the LymeShield System and Lyme disease vaccine demonstrates the company’s active development pipeline, suggesting potential sales for organizations involved in wildlife management, veterinary care, and public health initiatives targeting vector-borne diseases.

Strategic Partnerships Collaborations with pest control providers like JP McHale Pest Management highlight opportunities to expand market reach by integrating innovative oral vaccines into pest and vector control programs, especially in Lyme disease endemic areas.

Growing Market Focus The company’s focus on tick-borne diseases and influenza vaccines aligns with increasing public health and animal health concerns, providing avenues for targeted sales efforts to government agencies, healthcare providers, and animal care organizations.

Technology-Driven Growth US BIOLOGIC’s utilization of modern digital tools and partnerships indicates readiness to engage in scalable distribution and commercialization, making it a promising partner for organizations seeking innovative vaccine solutions in the biotech and healthcare sectors.